Certified by Founder
                                        Lodge
                                        
                                        
                                    
                                    
                                    ArkeaBio™
                                                                                start up
                                                                            
                                     United States
                                                 -                                                 Charlestown, Massachusetts
                                                                                                                                    
                                                                                                United States
                                                 -                                                 Charlestown, Massachusetts
                                                                                            
                                                                                    - 10/05/2024
- Series A
- $26,500,000
ArkeaBioTM is an ag-biotech start-up developing a safe, user-friendly, and cost-conscious vaccine to reduce ruminant methane emissions that will work seamlessly with existing global agribusiness practices.
- Industry Biotechnology Research
- Website https://www.arkeabio.com/
- LinkedIn https://www.linkedin.com/company/arkeabio/
Related People
Colin SouthFounder
 United States -
                                                         Boston, Massachusetts
                                                    
                                                                                                                United States -
                                                         Boston, Massachusetts
                                                    
                                                Experience leading dynamic, technically intense organizations in the Food, Life Sciences, and Energy sectors. Extensive engineering and science training and experience combined with management and technology leadership roles. Experience in high-profile executive roles with world-class teams to execute high-stakes management decisions. Business focus in complex roles; defining value capture strategies, establishing pathways to commercialization and overcoming complex business obstacles.
 Vesence |  $9,000,000  | (Oct 30, 2025)
                                Vesence |  $9,000,000  | (Oct 30, 2025) Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025) 
                             Reflectiz |  $22,000,000  | (Oct 30, 2025)
                                Reflectiz |  $22,000,000  | (Oct 30, 2025) 
                             
                                     
                                     
                                     
                                     
                                     
                                             
                                                 
                                                     
                                                     
                                                     
                                                     
                                                     
                                                 
                                                     
                                                 
                                                 
                                                 
                                                     
                                                 
                                                 
                                                 
                                                 
                                                 Mem0 |  $24,000,000  | (Oct 30, 2025)
                                                                        
                                Mem0 |  $24,000,000  | (Oct 30, 2025) Valthos |  $30,000,000  | (Oct 30, 2025)
                                                                        
                                Valthos |  $30,000,000  | (Oct 30, 2025) Mondra |  $13,206,500  | (Oct 30, 2025)
                                                                        
                                Mondra |  $13,206,500  | (Oct 30, 2025) 
                             hoop.dev |  Undisclosed Amount  | (Oct 30, 2025)
                                                                        
                                hoop.dev |  Undisclosed Amount  | (Oct 30, 2025) IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025) FrontlineIQ |  $3,300,000  | (Oct 30, 2025)
                                                                        
                                FrontlineIQ |  $3,300,000  | (Oct 30, 2025) Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025) VentureMed Inc. |  $28,000,000  | (Oct 30, 2025)
                                                                        
                                VentureMed Inc. |  $28,000,000  | (Oct 30, 2025) Recess |  $30,000,000  | (Oct 30, 2025)
                                                                        
                                Recess |  $30,000,000  | (Oct 30, 2025)